SALT LAKE CITY, UT--(Marketwire - March 06, 2008) - Myriad Genetics, Inc. (NASDAQ: MYGN), announced today that Adrian Hobden, Ph.D., President of Myriad Pharmaceuticals, Inc., is scheduled to present an overview of the Company at the 28th Annual Cowen Health Care Conference, at 10:15 a.m. on March 18, at the Boston Marriott Copley Place in Boston, Massachusetts.
